Showing results (531-540 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|September 5, 2007
Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodiumDrugs in R&D|August 7, 2020
Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical TrialsMarija Pesic, Thomas Stöhr, Joachim Ossig, et al.Drugs in R&D|March 29, 2021
Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After DiscontinuationSophie E Aapkes, Robbert J de Haas, Lucas H P Bernts, et al.Drugs in R&D|February 21, 2015
Auranofin: repurposing an old drug for a golden new ageChristine Roder, Melanie J ThomsonDrugs in R&D|February 6, 2003
Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. fDaoming Qiu, Peter N KaoDrugs in R&D|February 6, 2003
Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled studyTakahide Matsuda, Shigeaki Ohno, Shunsei Hirohata, et al.Drugs in R&D|April 30, 2003
Evaluation of the antiretroviral activity of a new polyherbal drug (Immu-25) in patients with HIV infectionP R Usha, M U R Naidu, Y S N RajuDrugs in R&D|July 10, 2003
Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415Drugs in R&D|November 29, 2002
Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled studyDomenico De Grandis, Chiara MinardiDrugs in R&D|March 21, 2013
Inhibitory effects of azelnidipine tablets on morning hypertensionKazuomi Kario, Yuki Sato, Masayuki Shirayama, et al.Pageof 90